09/09/2014 - 10:54am

AstraZeneca's once-weekly Bydureon (exenatide extended-release for injectable suspension) pen now is available in pharmacies across the United States, the company announced.

09/05/2014 - 1:11pm

Merck on Thursday announced that the Food and Drug Administration granted accelerated approval to Keytruda (pembrolizumab) for the treatment of patients with advanced melanoma.

09/05/2014 - 9:29am

Mylan on Friday announced that it has launched a generic version of Hoffmann-La Roche's Boniva injection.

09/05/2014 - 8:32am

Purdue Pharma on Thursday shared results from several studies evaluating its investigational pain medication Hysingla ER.

09/04/2014 - 9:33am

Teva Pharmaceutical on Thursday announced the launch of generic Baraclude (entecavir) tablets in 0.5-mg and 1-mg dosage strengths. The company was the first to file, giving it 180 days of marketing exclusivity for the drug. 

09/03/2014 - 3:25pm

Procter & Gamble on Wednesday announced the introduction of Vicks QlearQuil, a family of over-the-counter medications for the occasional allergy sufferer. 

09/03/2014 - 11:54am

PharmaSmart on Wednesday announced the debut of its next generation biometric kiosk, the Model PS2000 (D)estination, which recently completed a pilot inside Mariano’s, a grocer with 26 stores located in the Chicagoland Metro area. 

09/03/2014 - 8:48am

Abbott on Wednesday announced that it has received CE Mark (Conformite Europeenne) for its FreeStyle Libre Flash Glucose Monitoring System, a revolutionary new glucose-sensing technology for people with diabetes. 

08/27/2014 - 7:54am

GlaxoSmithKline announced that the Food and Drug Administration approved its supplemental new drug application for Promacta (eltrombopag), a once-daily medication for patients with severe aplastic anaemia who have had an insufficient response to immunosuppressive therapy.